Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-10-09

FDA Approved: DEXMETHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE — Original Application (Lannett Company, Inc.)

View source ↗

Summary

FDA approved the original application for a generic dexmethylphenidate hydrochloride extended-release product from Lannett Company, Inc., establishing a generic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • DEXMETHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE (dexmethylphenidate hydrochloride extended-release)

Snippet

ORIG AP for DEXMETHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE (DEXMETHYLPHENIDATE HYDROCHLORIDE)